Edward Conner
Chief Tech/Sci/R&D Officer at THIRD HARMONIC BIO, INC.
Net worth: - $ as of 2024-05-30
Network origin in Edward Conner first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
123
| Subsidiary | Biotechnology | 123 |
| Public Company | Biotechnology | 23 | |
| Subsidiary | Biotechnology | 21 | |
| Public Company | Pharmaceuticals: Major | 16 | |
13
| Extinct | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 13 | |
| Public Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Edward Conner via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin Undergraduate Degree Graduate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Compliance Officer Director/Board Member | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Investor Relations Contact | |
| RELYPSA INC | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
| Knox College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chairman Chairman Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Public Communications Contact Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Private Equity Investor | |
| Haas School of Business | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| CALITHERA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Administrative Officer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Founder Director/Board Member | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Cydan LLC
 Cydan LLC Medical DistributorsDistribution Services Cydan LLC operates as an orphan drug accelerator that identifies and de-risks programs. The firm's model evaluates programs for treating rare diseases with unmet medical need and is aimed at creating new companies to develop those therapies. The company was founded by James G. McArthur in 2013 and is headquartered in Cambridge, MA. | Medical Distributors | Director/Board Member Founder Director/Board Member | |
Tiburio Therapeutics, Inc.
 Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| PROTHENA CORPORATION PLC | Biotechnology | Chairman Chief Tech/Sci/R&D Officer Director/Board Member | |
| GRITSTONE BIO, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 47 |
| Switzerland | 2 |
| Canada | 2 |
| Ireland | 2 |
| Japan | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Finance | 4 |
| Health Services | 2 |
Operational
| Director/Board Member | 583 |
| Corporate Officer/Principal | 287 |
| Independent Dir/Board Member | 219 |
| Chairman | 110 |
| Chief Tech/Sci/R&D Officer | 94 |
Most connected contacts
| Insiders | |
|---|---|
| André S. Hoffmann | 52 |
| Charlie Sanders | 38 |
| Louis Lange | 35 |
| William Ringo | 32 |
| Robert Perez | 31 |
| Mette Agger | 30 |
| Joseph Zakrzewski | 30 |
| Karen Smith | 29 |
| J. Kenneth Charles Knowles | 29 |
| Patrick Yang | 28 |
| David Bonita | 27 |
| Mark Iwicki | 26 |
| Debra Reed-Klages | 26 |
| Mark Chin | 25 |
| Stéphane Boissel | 24 |
- Stock Market
- Insiders
- Edward Conner
- Company connections
